img

Global Rituximab Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rituximab Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Rituximab injection sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer.
Rituximab Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rituximab Injection market is projected to reach US$ 5851 million in 2029, increasing from US$ 1502 million in 2022, with the CAGR of 20.2% during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Rituximab Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Rituximab Injection key manufacturers include Pfizer, Amgen, Roche, Celltrion, Innovent Biologics, Intas Pharmaceuticals, Shanghai Henlius Biotech, Fosun-Pharmaceutical and Lexicare Pharma, etc. Pfizer, Amgen, Roche are top 3 players and held % sales share in total in 2022.
Rituximab Injection can be divided into 100 ml and 500 ml, etc. 100 ml is the mainstream product in the market, accounting for % sales share globally in 2022.
Rituximab Injection is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Rituximab Injection industry development. In 2022, global % sales of Rituximab Injection went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rituximab Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Amgen
Roche
Celltrion
Innovent Biologics
Intas Pharmaceuticals
Shanghai Henlius Biotech
Fosun-Pharmaceutical
Lexicare Pharma
Healthiza Lifescience
Kavya Pharma
Cadila Pharmaceuticals
Dr Reddy’s Laboratories
Hetero Group
Probiomed
TRPharma
Zenotech Laboratories
Segment by Type
100 ml
500 ml

Segment by Application


Hospitals
Clinics
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rituximab Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rituximab Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rituximab Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rituximab Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rituximab Injection introduction, etc. Rituximab Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Rituximab Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Rituximab Injection Market Overview
1.1 Rituximab Injection Product Overview
1.2 Rituximab Injection Market Segment by Type
1.2.1 100 ml
1.2.2 500 ml
1.3 Global Rituximab Injection Market Size by Type
1.3.1 Global Rituximab Injection Market Size Overview by Type (2018-2029)
1.3.2 Global Rituximab Injection Historic Market Size Review by Type (2018-2024)
1.3.3 Global Rituximab Injection Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Rituximab Injection Sales Breakdown by Type (2018-2024)
1.4.2 Europe Rituximab Injection Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Rituximab Injection Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Rituximab Injection Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Rituximab Injection Sales Breakdown by Type (2018-2024)
2 Global Rituximab Injection Market Competition by Company
2.1 Global Top Players by Rituximab Injection Sales (2018-2024)
2.2 Global Top Players by Rituximab Injection Revenue (2018-2024)
2.3 Global Top Players by Rituximab Injection Price (2018-2024)
2.4 Global Top Manufacturers Rituximab Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Rituximab Injection Market Competitive Situation and Trends
2.5.1 Rituximab Injection Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Rituximab Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rituximab Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Rituximab Injection Market
2.8 Key Manufacturers Rituximab Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Rituximab Injection Status and Outlook by Region
3.1 Global Rituximab Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Rituximab Injection Historic Market Size by Region
3.2.1 Global Rituximab Injection Sales in Volume by Region (2018-2024)
3.2.2 Global Rituximab Injection Sales in Value by Region (2018-2024)
3.2.3 Global Rituximab Injection Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Rituximab Injection Forecasted Market Size by Region
3.3.1 Global Rituximab Injection Sales in Volume by Region (2024-2029)
3.3.2 Global Rituximab Injection Sales in Value by Region (2024-2029)
3.3.3 Global Rituximab Injection Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Rituximab Injection by Application
4.1 Rituximab Injection Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Rituximab Injection Market Size by Application
4.2.1 Global Rituximab Injection Market Size Overview by Application (2018-2029)
4.2.2 Global Rituximab Injection Historic Market Size Review by Application (2018-2024)
4.2.3 Global Rituximab Injection Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Rituximab Injection Sales Breakdown by Application (2018-2024)
4.3.2 Europe Rituximab Injection Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Rituximab Injection Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Rituximab Injection Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Rituximab Injection Sales Breakdown by Application (2018-2024)
5 North America Rituximab Injection by Country
5.1 North America Rituximab Injection Historic Market Size by Country
5.1.1 North America Rituximab Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Rituximab Injection Sales in Volume by Country (2018-2024)
5.1.3 North America Rituximab Injection Sales in Value by Country (2018-2024)
5.2 North America Rituximab Injection Forecasted Market Size by Country
5.2.1 North America Rituximab Injection Sales in Volume by Country (2024-2029)
5.2.2 North America Rituximab Injection Sales in Value by Country (2024-2029)
6 Europe Rituximab Injection by Country
6.1 Europe Rituximab Injection Historic Market Size by Country
6.1.1 Europe Rituximab Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Rituximab Injection Sales in Volume by Country (2018-2024)
6.1.3 Europe Rituximab Injection Sales in Value by Country (2018-2024)
6.2 Europe Rituximab Injection Forecasted Market Size by Country
6.2.1 Europe Rituximab Injection Sales in Volume by Country (2024-2029)
6.2.2 Europe Rituximab Injection Sales in Value by Country (2024-2029)
7 Asia-Pacific Rituximab Injection by Region
7.1 Asia-Pacific Rituximab Injection Historic Market Size by Region
7.1.1 Asia-Pacific Rituximab Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Rituximab Injection Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Rituximab Injection Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Rituximab Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Rituximab Injection Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Rituximab Injection Sales in Value by Region (2024-2029)
8 Latin America Rituximab Injection by Country
8.1 Latin America Rituximab Injection Historic Market Size by Country
8.1.1 Latin America Rituximab Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Rituximab Injection Sales in Volume by Country (2018-2024)
8.1.3 Latin America Rituximab Injection Sales in Value by Country (2018-2024)
8.2 Latin America Rituximab Injection Forecasted Market Size by Country
8.2.1 Latin America Rituximab Injection Sales in Volume by Country (2024-2029)
8.2.2 Latin America Rituximab Injection Sales in Value by Country (2024-2029)
9 Middle East and Africa Rituximab Injection by Country
9.1 Middle East and Africa Rituximab Injection Historic Market Size by Country
9.1.1 Middle East and Africa Rituximab Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Rituximab Injection Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Rituximab Injection Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Rituximab Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Rituximab Injection Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Rituximab Injection Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Rituximab Injection Products Offered
10.1.5 Pfizer Recent Development
10.2 Amgen
10.2.1 Amgen Company Information
10.2.2 Amgen Introduction and Business Overview
10.2.3 Amgen Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Amgen Rituximab Injection Products Offered
10.2.5 Amgen Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Roche Rituximab Injection Products Offered
10.3.5 Roche Recent Development
10.4 Celltrion
10.4.1 Celltrion Company Information
10.4.2 Celltrion Introduction and Business Overview
10.4.3 Celltrion Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Celltrion Rituximab Injection Products Offered
10.4.5 Celltrion Recent Development
10.5 Innovent Biologics
10.5.1 Innovent Biologics Company Information
10.5.2 Innovent Biologics Introduction and Business Overview
10.5.3 Innovent Biologics Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Innovent Biologics Rituximab Injection Products Offered
10.5.5 Innovent Biologics Recent Development
10.6 Intas Pharmaceuticals
10.6.1 Intas Pharmaceuticals Company Information
10.6.2 Intas Pharmaceuticals Introduction and Business Overview
10.6.3 Intas Pharmaceuticals Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Intas Pharmaceuticals Rituximab Injection Products Offered
10.6.5 Intas Pharmaceuticals Recent Development
10.7 Shanghai Henlius Biotech
10.7.1 Shanghai Henlius Biotech Company Information
10.7.2 Shanghai Henlius Biotech Introduction and Business Overview
10.7.3 Shanghai Henlius Biotech Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Shanghai Henlius Biotech Rituximab Injection Products Offered
10.7.5 Shanghai Henlius Biotech Recent Development
10.8 Fosun-Pharmaceutical
10.8.1 Fosun-Pharmaceutical Company Information
10.8.2 Fosun-Pharmaceutical Introduction and Business Overview
10.8.3 Fosun-Pharmaceutical Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Fosun-Pharmaceutical Rituximab Injection Products Offered
10.8.5 Fosun-Pharmaceutical Recent Development
10.9 Lexicare Pharma
10.9.1 Lexicare Pharma Company Information
10.9.2 Lexicare Pharma Introduction and Business Overview
10.9.3 Lexicare Pharma Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Lexicare Pharma Rituximab Injection Products Offered
10.9.5 Lexicare Pharma Recent Development
10.10 Healthiza Lifescience
10.10.1 Healthiza Lifescience Company Information
10.10.2 Healthiza Lifescience Introduction and Business Overview
10.10.3 Healthiza Lifescience Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Healthiza Lifescience Rituximab Injection Products Offered
10.10.5 Healthiza Lifescience Recent Development
10.11 Kavya Pharma
10.11.1 Kavya Pharma Company Information
10.11.2 Kavya Pharma Introduction and Business Overview
10.11.3 Kavya Pharma Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Kavya Pharma Rituximab Injection Products Offered
10.11.5 Kavya Pharma Recent Development
10.12 Cadila Pharmaceuticals
10.12.1 Cadila Pharmaceuticals Company Information
10.12.2 Cadila Pharmaceuticals Introduction and Business Overview
10.12.3 Cadila Pharmaceuticals Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Cadila Pharmaceuticals Rituximab Injection Products Offered
10.12.5 Cadila Pharmaceuticals Recent Development
10.13 Dr Reddy’s Laboratories
10.13.1 Dr Reddy’s Laboratories Company Information
10.13.2 Dr Reddy’s Laboratories Introduction and Business Overview
10.13.3 Dr Reddy’s Laboratories Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Dr Reddy’s Laboratories Rituximab Injection Products Offered
10.13.5 Dr Reddy’s Laboratories Recent Development
10.14 Hetero Group
10.14.1 Hetero Group Company Information
10.14.2 Hetero Group Introduction and Business Overview
10.14.3 Hetero Group Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Hetero Group Rituximab Injection Products Offered
10.14.5 Hetero Group Recent Development
10.15 Probiomed
10.15.1 Probiomed Company Information
10.15.2 Probiomed Introduction and Business Overview
10.15.3 Probiomed Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Probiomed Rituximab Injection Products Offered
10.15.5 Probiomed Recent Development
10.16 TRPharma
10.16.1 TRPharma Company Information
10.16.2 TRPharma Introduction and Business Overview
10.16.3 TRPharma Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.16.4 TRPharma Rituximab Injection Products Offered
10.16.5 TRPharma Recent Development
10.17 Zenotech Laboratories
10.17.1 Zenotech Laboratories Company Information
10.17.2 Zenotech Laboratories Introduction and Business Overview
10.17.3 Zenotech Laboratories Rituximab Injection Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Zenotech Laboratories Rituximab Injection Products Offered
10.17.5 Zenotech Laboratories Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Rituximab Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Rituximab Injection Industrial Chain Analysis
11.4 Rituximab Injection Market Dynamics
11.4.1 Rituximab Injection Industry Trends
11.4.2 Rituximab Injection Market Drivers
11.4.3 Rituximab Injection Market Challenges
11.4.4 Rituximab Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Rituximab Injection Distributors
12.3 Rituximab Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 100 ml
Table 2. Major Company of 500 ml
Table 3. Global Rituximab Injection Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Rituximab Injection Sales by Type (2018-2024) & (K Units)
Table 5. Global Rituximab Injection Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Rituximab Injection Sales by Type (2018-2024) & (US& Million)
Table 7. Global Rituximab Injection Market Share in Value by Type (2018-2024)
Table 8. Global Rituximab Injection Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Rituximab Injection Sales by Type (2024-2029) & (K Units)
Table 10. Global Rituximab Injection Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Rituximab Injection Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Rituximab Injection Sales Market Share in Value by Type (2024-2029)
Table 13. Global Rituximab Injection Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Rituximab Injection Sales by Type (2018-2024) & (K Units)
Table 15. North America Rituximab Injection Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Rituximab Injection Sales (K Units) by Type (2018-2024)
Table 17. Europe Rituximab Injection Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Rituximab Injection Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Rituximab Injection Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Rituximab Injection Sales (K Units) by Type (2018-2024)
Table 21. Latin America Rituximab Injection Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Rituximab Injection Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Rituximab Injection Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Rituximab Injection Sales by Company (2018-2024) & (K Units)
Table 25. Global Rituximab Injection Sales Share by Company (2018-2024)
Table 26. Global Rituximab Injection Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Rituximab Injection Revenue Share by Company (2018-2024)
Table 28. Global Market Rituximab Injection Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Rituximab Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Rituximab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rituximab Injection as of 2022)
Table 32. Date of Key Manufacturers Enter into Rituximab Injection Market
Table 33. Key Manufacturers Rituximab Injection Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Rituximab Injection Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Rituximab Injection Sales by Region (2018-2024) & (K Units)
Table 37. Global Rituximab Injection Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Rituximab Injection Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Rituximab Injection Sales Market Share in Value by Region (2018-2024)
Table 40. Global Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Rituximab Injection Sales by Region (2024-2029) & (K Units)
Table 42. Global Rituximab Injection Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Rituximab Injection Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Rituximab Injection Sales Market Share in Value by Region (2024-2029)
Table 45. Global Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Rituximab Injection Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Rituximab Injection Sales by Application (2018-2024) & (K Units)
Table 48. Global Rituximab Injection Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Rituximab Injection Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Rituximab Injection Sales Market Share in Value by Application (2018-2024)
Table 51. Global Rituximab Injection Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Rituximab Injection Sales by Application (2024-2029) & (K Units)
Table 53. Global Rituximab Injection Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Rituximab Injection Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Rituximab Injection Sales Market Share in Value by Application (2024-2029)
Table 56. Global Rituximab Injection Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Rituximab Injection Sales by Application (2018-2024) (K Units)
Table 58. North America Rituximab Injection Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Rituximab Injection Sales by Application (2018-2024) (K Units)
Table 60. Europe Rituximab Injection Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Rituximab Injection Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Rituximab Injection Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Rituximab Injection Sales by Application (2018-2024) (K Units)
Table 64. Latin America Rituximab Injection Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Rituximab Injection Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Rituximab Injection Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Rituximab Injection Sales by Country (2018-2024) & (K Units)
Table 68. North America Rituximab Injection Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Rituximab Injection Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Rituximab Injection Sales Market Share in Value by Country (2018-2024)
Table 71. North America Rituximab Injection Sales by Country (2024-2029) & (K Units)
Table 72. North America Rituximab Injection Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Rituximab Injection Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Rituximab Injection Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Rituximab Injection Sales by Country (2018-2024) & (K Units)
Table 76. Europe Rituximab Injection Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Rituximab Injection Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Rituximab Injection Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Rituximab Injection Sales by Country (2024-2029) & (K Units)
Table 80. Europe Rituximab Injection Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Rituximab Injection Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Rituximab Injection Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Rituximab Injection Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Rituximab Injection Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Rituximab Injection Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Rituximab Injection Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Rituximab Injection Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Rituximab Injection Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Rituximab Injection Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Rituximab Injection Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Rituximab Injection Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Rituximab Injection Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Rituximab Injection Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Rituximab Injection Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Rituximab Injection Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Rituximab Injection Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Rituximab Injection Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Rituximab Injection Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Rituximab Injection Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Rituximab Injection Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Rituximab Injection Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Rituximab Injection Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Rituximab Injection Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Rituximab Injection Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Rituximab Injection Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Rituximab Injection Sales Market Share in Value by Country (2024-2029)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Rituximab Injection Product
Table 111. Pfizer Recent Development
Table 112. Amgen Company Information
Table 113. Amgen Introduction and Business Overview
Table 114. Amgen Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Amgen Rituximab Injection Product
Table 116. Amgen Recent Development
Table 117. Roche Company Information
Table 118. Roche Introduction and Business Overview
Table 119. Roche Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Roche Rituximab Injection Product
Table 121. Roche Recent Development
Table 122. Celltrion Company Information
Table 123. Celltrion Introduction and Business Overview
Table 124. Celltrion Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Celltrion Rituximab Injection Product
Table 126. Celltrion Recent Development
Table 127. Innovent Biologics Company Information
Table 128. Innovent Biologics Introduction and Business Overview
Table 129. Innovent Biologics Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Innovent Biologics Rituximab Injection Product
Table 131. Innovent Biologics Recent Development
Table 132. Intas Pharmaceuticals Company Information
Table 133. Intas Pharmaceuticals Introduction and Business Overview
Table 134. Intas Pharmaceuticals Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Intas Pharmaceuticals Rituximab Injection Product
Table 136. Intas Pharmaceuticals Recent Development
Table 137. Shanghai Henlius Biotech Company Information
Table 138. Shanghai Henlius Biotech Introduction and Business Overview
Table 139. Shanghai Henlius Biotech Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Shanghai Henlius Biotech Rituximab Injection Product
Table 141. Shanghai Henlius Biotech Recent Development
Table 142. Fosun-Pharmaceutical Company Information
Table 143. Fosun-Pharmaceutical Introduction and Business Overview
Table 144. Fosun-Pharmaceutical Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Fosun-Pharmaceutical Rituximab Injection Product
Table 146. Fosun-Pharmaceutical Recent Development
Table 147. Lexicare Pharma Company Information
Table 148. Lexicare Pharma Introduction and Business Overview
Table 149. Lexicare Pharma Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Lexicare Pharma Rituximab Injection Product
Table 151. Lexicare Pharma Recent Development
Table 152. Healthiza Lifescience Company Information
Table 153. Healthiza Lifescience Introduction and Business Overview
Table 154. Healthiza Lifescience Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Healthiza Lifescience Rituximab Injection Product
Table 156. Healthiza Lifescience Recent Development
Table 157. Kavya Pharma Company Information
Table 158. Kavya Pharma Introduction and Business Overview
Table 159. Kavya Pharma Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Kavya Pharma Rituximab Injection Product
Table 161. Kavya Pharma Recent Development
Table 162. Cadila Pharmaceuticals Company Information
Table 163. Cadila Pharmaceuticals Introduction and Business Overview
Table 164. Cadila Pharmaceuticals Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Cadila Pharmaceuticals Rituximab Injection Product
Table 166. Cadila Pharmaceuticals Recent Development
Table 167. Dr Reddy’s Laboratories Company Information
Table 168. Dr Reddy’s Laboratories Introduction and Business Overview
Table 169. Dr Reddy’s Laboratories Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Dr Reddy’s Laboratories Rituximab Injection Product
Table 171. Dr Reddy’s Laboratories Recent Development
Table 172. Hetero Group Company Information
Table 173. Hetero Group Introduction and Business Overview
Table 174. Hetero Group Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Hetero Group Rituximab Injection Product
Table 176. Hetero Group Recent Development
Table 177. Probiomed Company Information
Table 178. Probiomed Introduction and Business Overview
Table 179. Probiomed Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Probiomed Rituximab Injection Product
Table 181. Probiomed Recent Development
Table 182. TRPharma Company Information
Table 183. TRPharma Introduction and Business Overview
Table 184. TRPharma Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. TRPharma Rituximab Injection Product
Table 186. TRPharma Recent Development
Table 187. Zenotech Laboratories Company Information
Table 188. Zenotech Laboratories Introduction and Business Overview
Table 189. Zenotech Laboratories Rituximab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 190. Zenotech Laboratories Rituximab Injection Product
Table 191. Zenotech Laboratories Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Rituximab Injection Market Trends
Table 195. Rituximab Injection Market Drivers
Table 196. Rituximab Injection Market Challenges
Table 197. Rituximab Injection Market Restraints
Table 198. Rituximab Injection Distributors List
Table 199. Rituximab Injection Downstream Customers
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Rituximab Injection Product Picture
Figure 2. Global Rituximab Injection Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Rituximab Injection Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Rituximab Injection Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 100 ml
Figure 6. Global 100 ml Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 500 ml
Figure 8. Global 500 ml Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Rituximab Injection Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Rituximab Injection Sales Market Share by Type in 2022 & 2029
Figure 11. North America Rituximab Injection Sales Market Share in Volume by Type in 2022
Figure 12. North America Rituximab Injection Sales Market Share in Value by Type in 2022
Figure 13. Europe Rituximab Injection Sales Market Share in Volume by Type in 2022
Figure 14. Europe Rituximab Injection Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Rituximab Injection Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Rituximab Injection Sales Market Share in Value by Type in 2022
Figure 17. Latin America Rituximab Injection Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Rituximab Injection Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Rituximab Injection Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Rituximab Injection Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Rituximab Injection Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Rituximab Injection Revenue in 2022
Figure 23. Rituximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospitals
Figure 25. Global Hospitals Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Clinics
Figure 27. Global Clinics Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Rituximab Injection Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Rituximab Injection Sales Market Share by Application in 2022 & 2029
Figure 32. North America Rituximab Injection Sales Market Share in Volume by Application in 2022
Figure 33. North America Rituximab Injection Sales Market Share in Value by Application in 2022
Figure 34. Europe Rituximab Injection Sales Market Share in Volume by Application in 2022
Figure 35. Europe Rituximab Injection Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Rituximab Injection Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Rituximab Injection Sales Market Share in Value by Application in 2022
Figure 38. Latin America Rituximab Injection Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Rituximab Injection Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Rituximab Injection Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Rituximab Injection Manufacturing Cost Structure
Figure 43. Rituximab Injection Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries